Homovanillic acid (HVA) urinary excretion and day/night rhythm of chronic schizophrenic patients. Preliminary observations. 1985

P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux

The authors report, as compared to healthy subjects, a higher daily excretion and a higher urinary variations of homovanillic acid (HVA) for schizophrenic chronic paranoid patients (patients with positive symptomatology predominating, CROW,s type I). Inversely, a lower HVA excretion and probably an inversion of the circadian rhythm of urinary HVA were found for schizophrenic chronic undifferentiated patients (patients with negative symptomatology predominating, CROW's type II). These results have to be confirmed by the study of a greater number of patients and the measure, for comparison among themselves, of other precursors and metabolites of monoamines.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001683 Biological Clocks The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena. Biological Oscillators,Oscillators, Endogenous,Pacemakers, Biological,Biologic Clock,Biologic Oscillator,Biological Pacemakers,Clock, Biologic,Clocks, Biological,Oscillator, Biologic,Oscillators, Biological,Pacemaker, Biologic,Pacemakers, Biologic,Biologic Clocks,Biologic Oscillators,Biologic Pacemaker,Biologic Pacemakers,Biological Clock,Biological Oscillator,Biological Pacemaker,Clock, Biological,Clocks, Biologic,Endogenous Oscillator,Endogenous Oscillators,Oscillator, Biological,Oscillator, Endogenous,Oscillators, Biologic,Pacemaker, Biological
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012563 Schizophrenia, Paranoid A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Delusional Disorder,Paranoid Schizophrenia,Delusional Disorders,Disorder, Delusional,Disorders, Delusional,Paranoid Schizophrenias,Schizophrenias, Paranoid

Related Publications

P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
June 1998, Acta psychiatrica Scandinavica,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
May 1973, Gut,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
August 1966, American journal of ophthalmology,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
March 1973, Journal of psychosomatic research,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
January 1998, Biological trace element research,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
May 1971, Research communications in chemical pathology and pharmacology,
P Mathieu, and P Lemoine, and M Szestak, and J Greffe, and N Gros, and C Echassoux
January 1997, Pediatric hematology and oncology,
Copied contents to your clipboard!